Health Invest Partners Ab has filed its 13F form on February 04, 2025 for Q4 2024 where it was disclosed a total value porftolio of $208 Million distributed in 36 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $28.6M, Unitedhealth Group Inc with a value of $17.8M, Abb Vie Inc. with a value of $16.1M, Boston Scientific Corp with a value of $13.8M, and Thermo Fisher Scientific Inc. with a value of $13M.

Examining the 13F form we can see an increase of $2.12M in the current position value, from $206M to 208M.

Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.

Portfolio value $208 Million
Healthcare: $208 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 36
  • Current Value $208 Million
  • Prior Value $206 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 04, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 3 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.